
California sees surge in use of weight loss drugs like Wegovy
"Before now, there hasn’t been much information available on patient-level, longitudinal use patterns, and the recent FDA approval of GLP-1 RAs linked to substantial weight loss has generated great interest in demand projections." (Jonathan Watanabe)